CNMD CONMED Corporation
$45.76▼ -3.05%
Healthcare
Other
After hours
$45.85▲ +0.19%
Oct 28, 4:46 PM ET
Volume 610.2K
Avg Volume (10D) 406.8K
Key Metrics & Fundamentals
Market Cap
$1.37B
P/E Ratio
24.7
Div Yield
0.00%
52W Range
31.44 - 53.66
% vs 50 MA
-3.31%
% vs 200 MA
10.62%
RSI-14
45.9
MACD Histogram
+0.1100
Beta (1Y vs SPY)
0.73
Free Cash Flow
$34.16M
Gross Rev
$343.49M
Gross Profit
$197.46M
EBITDA
$58.28M
COGS
$146.03M
Operating Exp
$161.05M
Operating Income
$36.41M
EBIT
$36.41M
Pretax Income
$31.35M
Net Income
$23.07M
EPS (Diluted)
0.77
Price & Volume History
Loading chart…
Recent News

Conmed (CNMD) Q3 Earnings Top Estimates
Zacks · Oct 28, 2026 6:30 PM ET

Here's What Key Metrics Tell Us About Conmed (CNMD) Q3 Earnings
Zacks · Oct 28, 2026 6:00 PM ET

CONMED (NYSE:CNMD) posts Q3 2026 sales in line with estimates
StockStory · Oct 28, 2026 5:11 PM ET
Conmed: Q3 Earnings Snapshot
Associated Press · Oct 28, 2026 4:56 PM ET

CONMED Corporation Reports Third Quarter 2026 Financial Results; Updates Full Year 2026 Guidance
Business Wire · Oct 28, 2026 4:05 PM ET

What to expect from CONMED’s (CNMD) Q3 earnings
StockStory · Oct 27, 2026 6:06 AM ET

3 Low-Volatility Stocks with Questionable Fundamentals
StockStory · Oct 16, 2026 9:15 AM ET

Surgical Equipment & Consumables - Diversified Stocks Q2 Recap: Benchmarking CONMED (NYSE:CNMD)
StockStory · Oct 2, 2026 2:30 PM ET

CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026
Business Wire · Oct 1, 2026 4:05 PM ET

3 Value Stocks That Concern Us
StockStory · Sep 24, 2026 6:40 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CNMD's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.